1Gunderson LL, Haddock MG, Goldberg R, et al. Alimentary cancer.In: Rubin P ,Williams JP .eds. Clinical Oncology: a mudtidisciplinary approach for physicians and students. 8th. New York: W. B. Saunders Company, 2001. 689-716.
2Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction. N Engl J Med, 2001, 345: 725-730.
3Lokich JJ, Sonnebom H, Anderson NR, et al. Combined paclitaxel,cisplatin, and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas. Cancer, 1999, 85:2347-2351.
7Macdonald JS, Smalley SR,Benedetti J,et al. Chemoradiotherapy aftersurgery compared with surgery alone foradenocarcinoma of the stomach or gas-troesophageal junction[J]. N Engl J Med, 2001,345 (10) : 725-730.
8Gunderson LL,Sosin H. Adenocarcinoma of thestomach., areas of failure in a reoperation series (second or symptomatic looks): clinicopathologiceorrelation and implications for adjuvant therapy[J]. Int J Radiat Oncol Biol Phys, 1982,8 (1) : 1-5.
9Gunderson LL. Gastric cancer--patterns of relapse after surgical resection [ J ]. Semin Radiat Oneol, 2002,12 (2) : 150-161.
10Wydmanski J, Suwinski R, Miszczyk L, et al. Evaluation of tolerance and efficacy of postoperative combined radiotherapy and chemotherapy in locally advanced gastric cancer [ J ]. Przegl Lek, 2005, 62(12) :1431-1435.
